Ingevity Corporation
NGVT Basic Materials Specialty Chemicals
Ingevity Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, down 2.71% from fiscal 2024.
- Revenue
- −5.25%
- EPS
- +125.4%
- Free cash flow
- −136.1%
- Total debt
- −14.5%
Quarter to June 2026, against a year earlier
Follow NGVT
Alert me
Ingevity Corporation (NGVT) P/E ratio
As of 5 November 2026, Ingevity Corporation (NGVT) trades at a P/E ratio of 42.0×. Over the past ten years it has ranged from 0.0× (June 2026) to 77.3× (March 2017); the current reading is higher than 87% of that period. That is above the Specialty Chemicals industry median of 24.5× and above the Basic Materials sector median of 19.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 12.9× | (47.07%) |
| FY2021 | 24.3× | 44.75% |
| FY2020 | 16.8× | (15.83%) |
| FY2019 | 19.9× | (3.93%) |
| FY2018 | 20.8× | (12.43%) |
| FY2017 | 23.7× | (64.32%) |
| FY2016 | 66.5× | 305.82% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 48.5× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CC The Chemours Company compare | n/m |
| MTX Minerals Technologies Inc. compare | n/m |
| FUL H. B. Fuller Company compare | 13.8× |
| IOSP Innospec Inc. compare | 13.9× |
| KWR Quaker Houghton compare | 27.2× |
| HWKN Hawkins, Inc. compare | 36.6× |
| WDFC WD-40 Company compare | 37.0× |
| NGVT Ingevity Corporation | 42.0× |
| STDN Standard Nuclear Inc compare | — |
| Specialty Chemicals industry median | 24.5× |
| Basic Materials sector median | 19.0× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on NGVT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement